Showing 1 - 9 results of 9 for search 'Ashley S Harms', query time: 0.05s Refine Results
  1. 1
    Editorial: Glial-targeted therapeutics for CNS disease: getting there from here

    Editorial: Glial-targeted therapeutics for CNS disease: getting there from here by Malú Gámez Tansey, Ashley S. Harms

    Published 2023-07-01
    Get full text
    Article
  2. 2
    Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease.

    Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease. by Aaron D Thome, David G Standaert, Ashley S Harms

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Fiber-Modified Adenovirus for Central Nervous System Parkinson’s Disease Gene Therapy

    Fiber-Modified Adenovirus for Central Nervous System Parkinson’s Disease Gene Therapy by Travis B. Lewis, Joel N. Glasgow, Ashley S. Harms, David G. Standaert, David T. Curiel

    Published 2014-08-01
    Get full text
    Article
  4. 4
    Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease

    Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease by Gregory P. Williams, Aubrey M. Schonhoff, Asta Jurkuvenaite, Aaron D. Thome, David G. Standaert, Ashley S. Harms

    Published 2018-08-01
    Get full text
    Article
  5. 5
    α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration

    α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration by Ashley S. Harms, Vedad Delic, Aaron D. Thome, Nicole Bryant, Zhiyong Liu, Sidhanth Chandra, Asta Jurkuvenaite, Andrew B. West

    Published 2017-11-01
    Get full text
    Article
  6. 6
    IFNγ drives neuroinflammation, demyelination, and neurodegeneration in a mouse model of multiple system atrophy

    IFNγ drives neuroinflammation, demyelination, and neurodegeneration in a mouse model of multiple system atrophy by Nicole J. Corbin-Stein, Gabrielle M. Childers, Jhodi M. Webster, Asta Zane, Ya-Ting Yang, Nikhita Mudium, Rajesh Gupta, Fredric P. Manfredsson, Jeffrey H. Kordower, Ashley S. Harms

    Published 2024-01-01
    Get full text
    Article
  7. 7
    Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease

    Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease by Samantha M. Carlisle, Hongwei Qin, R. Curtis Hendrickson, Jordana E. Muwanguzi, Elliot J. Lefkowitz, Richard E. Kennedy, Zhaoqi Yan, Talene A. Yacoubian, Etty N. Benveniste, Andrew B. West, Ashley S. Harms, David G. Standaert

    Published 2021-04-01
    Get full text
    Article
  8. 8
    Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology

    Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology by Fiona E. McAlpine, Jae-Kyung Lee, Ashley S. Harms, Kelly A. Ruhn, Mathew Blurton-Jones, John Hong, Pritam Das, Todd E. Golde, Frank M. LaFerla, Salvatore Oddo, Armin Blesch, Malú G. Tansey

    Published 2009-04-01
    Get full text
    Article
  9. 9
    Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain

    Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain by Enquan Xu, Ravindra Boddu, Hisham A. Abdelmotilib, Arpine Sokratian, Kaela Kelly, Zhiyong Liu, Nicole Bryant, Sidhanth Chandra, Samantha M. Carlisle, Elliot J. Lefkowitz, Ashley S. Harms, Etty N. Benveniste, Talene A. Yacoubian, Laura A. Volpicelli-Daley, David G. Standaert, Andrew B. West

    Published 2022-01-01
    Get full text
    Article

Search Tools: